Skip to main content

Advertisement

Log in

Long-term efficacy of intravenously administered immunoglobulin in a case of polymyositis with limited application of steroid therapy

  • Case Report
  • Published:
Modern Rheumatology

Abstract

A 72-year-old man who had been diagnosed with polymyositis (PM) was admitted to our hospital for pneumonia with exacerbation of muscle weakness, elevation of muscle enzymes, and positive magnetic resonance imaging findings. The patient had been refractory to cyclosporine A or azathioprine and hoped to avoid administration of high-dose steroids; IV immunoglobulin (IVIG) was therefore administered after improvement of the pneumonia. Two weeks after the IVIG therapy, muscle test scores, activities of daily living, and muscle enzymes were drastically improved. Twenty months after IVIG, no relapse of PM was observed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

ADL:

Activities of daily living

ALD:

Aldolase

AST:

Aspartate aminotransferase

AZP:

Azathioprine

CK:

Creatinine kinase

CyA:

Cyclosporine A

DM:

Dermatomyositis

IVIG:

Intravenous immunoglobulin

MMT:

Manual muscle test scores

MRI:

Magnetic resonance imaging

PM:

Polymyositis

STIR:

Short tau inversion recovery

References

  1. Wiendl H. Idiopathic inflammatory myopathies: current and future therapeutic options. Neurotherapeutics. 2008;5:548–57.

    Article  CAS  PubMed  Google Scholar 

  2. Amato AA, Barohn RJ. Evaluation and treatment of inflammatory myopathies. J Neurol Neurosurg Psychiatry. 2009;80:1060–8.

    Article  CAS  PubMed  Google Scholar 

  3. Hengstman GJ, van den Hoogen FH, van Engelen BG. Treatment of the inflammatory myopathies: update and practical recommendations. Expert Opin Pharmacother. 2009;10:1183–90.

    Article  CAS  PubMed  Google Scholar 

  4. Dalakas MC. Intravenous immunoglobulin in autoimmune neuromuscular diseases. JAMA. 2004;291:2367–75.

    Article  CAS  PubMed  Google Scholar 

  5. Dalakas MC, Illa I, Dambrosia JM, Soueidan SA, Stein DP, Otero C, et al. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med. 1993;329:1993–2000.

    Article  CAS  PubMed  Google Scholar 

  6. Saito E, Koike T, Hashimoto H, Miyasaka N, Ikeda Y, Hara M, et al. Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis. Mod Rheumatol. 2008;18:34–44.

    Article  CAS  PubMed  Google Scholar 

  7. Cherin P, Pelletier S, Teixeira A, Laforet P, Genereau T, Simon A, et al. Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients. Arthritis Rheum. 2002;46:467–74.

    Article  CAS  PubMed  Google Scholar 

  8. Genevay S, Saudan-Kister A, Guerne PA. Intravenous gammaglobulins in refractory polymyositis: lower dose for maintenance treatment is effective. Ann Rheum Dis. 2001;60:635–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest statement

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hideki Nakamura.

About this article

Cite this article

Nakamura, H., Fujikawa, K., Kawakami, A. et al. Long-term efficacy of intravenously administered immunoglobulin in a case of polymyositis with limited application of steroid therapy. Mod Rheumatol 20, 496–499 (2010). https://doi.org/10.1007/s10165-010-0298-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10165-010-0298-2

Keywords

Navigation